gptkbp:instanceOf
|
gptkb:biotechnology
|
gptkbp:acquiredBy
|
gptkb:Genzyme_(2011)
gptkb:Synthorx_(2020)
Ablynx (2018)
Bioverativ (2018)
Principia Biopharma (2020)
|
gptkbp:CEO
|
gptkb:Paul_Hudson
|
gptkbp:country
|
gptkb:France
|
gptkbp:divested
|
gptkb:Merial_(2017)
gptkb:Zentiva_(2018)
European generics business (2018)
|
gptkbp:founded
|
2004
|
gptkbp:headquarters
|
gptkb:Paris
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sanofi (after 2004)
|
gptkbp:industry
|
pharmaceuticals
|
gptkbp:keyPerson
|
gptkb:Thomas_Triomphe
gptkb:John_Reed
gptkb:Paul_Hudson
gptkb:Serge_Weinberg
gptkb:Jean-Baptiste_Chasseloup_de_Chatillon
gptkb:Julie_Van_Ongevalle
gptkb:Natalie_Bickford
gptkb:Olivier_Charmeil
gptkb:Philippe_Luscan
|
gptkbp:language
|
gptkb:French
English
|
gptkbp:listedOn
|
gptkb:CAC_40
gptkb:NYSE_Arca_Pharmaceutical_Index
gptkb:S&P_Euro_350
|
gptkbp:marketCap
|
~€110 billion (2023)
|
gptkbp:memberOf
|
gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
|
gptkbp:netIncome
|
€5.8 billion (2023)
|
gptkbp:notableEvent
|
COVID-19 vaccine development
Acquisition of Ablynx (2018)
Acquisition of Bioverativ (2018)
Acquisition of Principia Biopharma (2020)
Acquisition of Synthorx (2020)
Divestment of animal health division Merial (2017)
Merger of Sanofi-Synthélabo and Aventis (2004)
Rebranding from Sanofi-Aventis to Sanofi (2011)
|
gptkbp:numberOfEmployees
|
~91,000
|
gptkbp:predecessor
|
gptkb:Sanofi-Synthélabo
gptkb:Aventis
|
gptkbp:product
|
gptkb:Soliqua
gptkb:Aldurazyme
gptkb:Myozyme
gptkb:Cerdelga
gptkb:Aubagio
gptkb:Clexane
gptkb:Dupixent
gptkb:Kevzara
gptkb:Lantus
gptkb:Plavix
gptkb:Praluent
gptkb:Toujeo
gptkb:Jevtana
gptkb:Lemtrada
gptkb:Multaq
Vaccines (various)
|
gptkbp:products
|
vaccines
pharmaceutical drugs
consumer healthcare products
|
gptkbp:publiclyTraded
|
true
|
gptkbp:R&DSpending
|
€6.7 billion (2023)
|
gptkbp:revenue
|
€43.07 billion (2023)
|
gptkbp:servesArea
|
worldwide
|
gptkbp:stockExchange
|
gptkb:NASDAQ
gptkb:Euronext_Paris
|
gptkbp:stockSymbol
|
gptkb:SNY
SAN
|
gptkbp:subsidiary
|
gptkb:Sanofi_Pasteur
gptkb:Genzyme
gptkb:Chattem
|
gptkbp:website
|
https://www.sanofi.com/
|
gptkbp:bfsParent
|
gptkb:Rhône-Poulenc
|
gptkbp:bfsLayer
|
6
|